Skip to main content
. 2014 Feb 4;18(5):863–874. doi: 10.1111/jcmm.12232

Fig. 2.

Fig. 2

Olfactomedin 4 (OLFM4), oestrogen receptor-α (ERα) and progesterone receptor (PR) mRNA level in endometrial tissues measured by real-time RT-PCR. (A) OLFM4 mRNA level in normal endometrium, endometrial hyperplasia and endometrioid adenocarcinoma. (B) OLFM4 mRNA level in well-, moderately- and poorly-differentiated endometrioid adenocarcinomas. (C) ERα mRNA level in normal endometrium, endometrial hyperplasia and endometrioid adenocarcinoma. (D) PR mRNA level in normal endometrium, endometrial hyperplasia and endometrioid adenocarcinoma. For multiple comparisons between groups the significance level was adjusted to 0.05/3 = 0.017. #P < 0.017, **P < 0.001. NE: normal endometrium; EH: endometrial hyperplasia; EAC: endometrioid adenocarcinoma.